Approval · Notice of Compliance 1852 · 1999
MED INDAPAMIDE: Notice of Compliance 1852
Issued October 7, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1852
- Date
- October 7, 1999
- Company
- Medican Pharma IncorporatedKitchener, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anti-hypertensive/diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MED INDAPAMIDE | 02241018 | — |
Medicinal ingredients
- INDAPAMIDE HEMIHYDRATE 1.25 MG per TAB